Teva reports fourth quarter and full year 2022 financial results

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) today reported results for the year and the quarter ended december 31, 2022. q4 and fy 2022 highlights:   q4 2022 fy 2022 revenues   $3.9 billion   $14.9 billion gaap diluted loss per share   $(1.10)   $(2.12) non-gaap diluted eps   $0.71   $2.
TEVA Ratings Summary
TEVA Quant Ranking